Interplay between hypoxia and inflammation contributes to the progression and severity of respiratory viral diseases

S Bhattacharya, S Agarwal, NM Shrimali… - Molecular Aspects of …, 2021 - Elsevier
History of pandemics is dominated by viral infections and specifically respiratory viral
diseases like influenza and COVID-19. Lower respiratory tract infection is the fourth leading …

Early-life respiratory syncytial virus infection, trained immunity and subsequent pulmonary diseases

CA Malinczak, NW Lukacs, W Fonseca - Viruses, 2020 - mdpi.com
Respiratory syncytial virus (RSV) is often the first clinically relevant pathogen encountered in
life, with nearly all children infected by two years of age. Many studies have also linked early …

[HTML][HTML] A three-dimensional A549 cell culture model to study respiratory syncytial virus infections

F Saleh, A Harb, N Soudani, H Zaraket - Journal of Infection and Public …, 2020 - Elsevier
Background Respiratory syncytial virus (RSV) is a primary cause of morbidity and mortality
worldwide, affecting infants, young children, and immune-compromised patients; however …

Gold nanorods inhibit respiratory syncytial virus by stimulating the innate immune response

SS Bawage, PM Tiwari, A Singh, S Dixit… - … , Biology and Medicine, 2016 - Elsevier
Respiratory syncytial virus (RSV) causes severe pneumonia and bronchiolitis in infants,
children and older adults. The use of metallic nanoparticles as potential therapeutics is …

Human respiratory syncytial virus infections among hospitalized children in Poland during 2010–2020: Study based on the national hospital registry

M Rząd, K Kanecki, K Lewtak, P Tyszko… - Journal of Clinical …, 2022 - mdpi.com
Background: Human respiratory syncytial virus (RSV) is responsible for infections mainly
affecting the lower respiratory tract in infants and young children after the first exposure. The …

Novel respiratory syncytial virus-like particle vaccine composed of the postfusion and prefusion conformations of the F glycoprotein

V Cimica, H Boigard, B Bhatia, JT Fallon… - Clinical and Vaccine …, 2016 - Am Soc Microbiol
Respiratory syncytial virus (RSV) is the leading cause of severe respiratory disease in
infants and children and represents an important global health burden for the elderly and the …

[HTML][HTML] Respiratory syncytial virus infection: an innate perspective

C Johansson - F1000Research, 2016 - ncbi.nlm.nih.gov
Respiratory syncytial virus (RSV) is a common cause of upper respiratory tract infection in
children and adults. However, infection with this virus sometimes leads to severe lower …

Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective

Y Chan, SW Ng, SK Singh, M Gulati, G Gupta… - Life sciences, 2021 - Elsevier
Viral respiratory tract infections have significantly impacted global health as well as socio-
economic growth. Respiratory viruses such as the influenza virus, respiratory syncytial virus …

A multi-center study to determine genetic variations in the fusion gene of respiratory syncytial virus (RSV) from children< 2 years of age in the US

B Adhikari, F Hassan, CJ Harrison, JD Bard… - Journal of Clinical …, 2022 - Elsevier
The fusion (F) protein of respiratory syncytial virus (RSV) is the major target of
immunoprophylactic monoclonal antibodies (mAbs) and vaccines. Recently reported …

RSV in adult ED patients: do emergency providers consider RSV as an admission diagnosis?

W Binder, J Thorsen, P Borczuk - The American journal of emergency …, 2017 - Elsevier
Abstract Background Respiratory Syncytial Virus (RSV) has been recognized for over half a
century as a cause of morbidity in infants and children. Over the past 20 years, data has …